Individual Study / SRI_Exposure

Early child development and the effects of prenatal antidepressant exposure

Early child development and the effects of prenatal antidepressant exposure

Initiatives -
The objective of this study was to investigate the effects of prenatal exposure to serotonin reuptake inhibitors (SRIs) antidepressants on the developing child extending from fetal periods into childhood. The study included SSRIs and SNRIs.
Start Year
2002
Visit SRI_Exposure

Members

Download
Investigators Contacts
  • Dr. Prof. Tim Oberlander
    University of British Columbia

Design

Study design
Population cohort
Follow Up
Participants were assessed at 26 weeks gestation, 33 to 36 weeks gestation, at delivery, during the neonatal period 1st week, 6 week postpartum, 3 month postpartum, 6 month postpartum, 10 month postpartum, 3 years, 5 to 7 years and 9 to 14 years.

Marker Paper

Brummelte S., Mc Glanaghy E., Bonnin A., Oberlander T.F. Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptation.Neuroscience. 2017 Feb; 7(342):212-231.

PUBMED 26905950

Recruitment

Sources of Recruitment
  • Families

Number of participants

Number of participants
550
Number of participants with biosamples

Access

Availability of data and biosamples

Data
Biosamples
Other

Availability of access information

By contacting the study representative